Literature DB >> 33502654

Echocardiographic screening for mitral valve prolapse in Turkish school children.

Utku Çağlayan1, Mehmet Gökhan Ramoğlu2, Semra Atalay3, Tayfun Uçar3, Ercan Tutar3.   

Abstract

We determined the frequency of mitral valve prolapse (MVP) in healthy Turkish school children using the current echocardiographic diagnostic criteria. This epidemiological survey was performed on 2550 school children. All children were screened with echocardiography and the family of children with MVP were also screened. The prolapse of mitral leaflets into left atrium ≥ 2 mm in parasternal long-axis view was used as diagnostic criteria. MVP was classified as classical or non-classical according to anterior mitral leaflet thickness. The thickness of anterior mitral leaflet, the extent of prolapse, and the presence of mitral regurgitation were evaluated. The children were also questioned about the associated symptoms. The prevalence of MVP was 1.25% in children with a mean age of 11.1 ± 2.9 years. The prevalence was 0.9%, 1.2%, and 1.6% in 5-9 years, 10-13 years, and 14-18 years of age, respectively. 43.7% of the cases were classical MVP. The frequency of auscultation findings was 34.3%. 11/34 children had mitral regurgitation. There was no statistically significant difference between classical MVP and non-classical MVP in terms of mitral regurgitation, physical examination findings, and symptoms. Anxiety (37.5%) was the most common symptom. The frequency of MVP in the first-degree relatives of children with MVP was 11/84 (13.1%). Most patients with MVP don't have auscultation findings and symptoms, therefore echocardiography is an important tool in the diagnosis of MVP. It is also reasonable to screen first degree relatives of MVP patients with echocardiography.

Entities:  

Keywords:  Auscultation; Echocardiography; Mitral valve prolapse

Year:  2021        PMID: 33502654     DOI: 10.1007/s10554-020-02150-7

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  29 in total

1.  Thoracic skeletal abnormalities in idiopathic mitral valve prolapse.

Authors:  J Salomon; P M Shah; R A Heinle
Journal:  Am J Cardiol       Date:  1975-07       Impact factor: 2.778

2.  Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves.

Authors:  E Rabkin; M Aikawa; J R Stone; Y Fukumoto; P Libby; F J Schoen
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

Review 3.  Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis.

Authors:  Francesca N Delling; Ramachandran S Vasan
Journal:  Circulation       Date:  2014-05-27       Impact factor: 29.690

Review 4.  ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.

Authors:  Robert O Bonow; Blase A Carabello; Chatterjee Kanu; Antonio C de Leon; David P Faxon; Michael D Freed; William H Gaasch; Bruce Whitney Lytle; Rick A Nishimura; Patrick T O'Gara; Robert A O'Rourke; Catherine M Otto; Pravin M Shah; Jack S Shanewise; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-08-01       Impact factor: 29.690

5.  Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve.

Authors:  K Tamura; Y Fukuda; M Ishizaki; Y Masuda; N Yamanaka; V J Ferrans
Journal:  Am Heart J       Date:  1995-06       Impact factor: 4.749

6.  Mitral valve prolapse in the general population. 2. Clinical features: the Framingham Study.

Authors:  D D Savage; R B Devereux; R J Garrison; W P Castelli; S J Anderson; D Levy; H E Thomas; W B Kannel; M Feinleib
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

7.  Prevalence and clinical outcome of mitral-valve prolapse.

Authors:  L A Freed; D Levy; R A Levine; M G Larson; J C Evans; D L Fuller; B Lehman; E J Benjamin
Journal:  N Engl J Med       Date:  1999-07-01       Impact factor: 91.245

8.  Prolapse of the mitral valve: clinical and cine-angiocardiographic findings.

Authors:  J M Criley; K B Lewis; J O Humphries; R S Ross
Journal:  Br Heart J       Date:  1966-07

Review 9.  Genetics of syndromic and non-syndromic mitral valve prolapse.

Authors:  Thierry Le Tourneau; Jean Mérot; Antoine Rimbert; Solena Le Scouarnec; Vincent Probst; Hervé Le Marec; Robert A Levine; Jean-Jacques Schott
Journal:  Heart       Date:  2018-01-19       Impact factor: 5.994

10.  Relation between clinical features of the mitral prolapse syndrome and echocardiographically documented mitral valve prolapse.

Authors:  R B Devereux; R Kramer-Fox; W T Brown; M K Shear; N Hartman; P Kligfield; E M Lutas; M C Spitzer; S D Litwin
Journal:  J Am Coll Cardiol       Date:  1986-10       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.